Peripheral blood stem cell collection in children with extremely low body weight (≤8 kg). What have we learned over the past 25 years and where are the limits?
Victoria GrèzeNadège RouelEmmanuelle RochetteEtienne MerlinPascale HalleDominique PlantazFrançois DeméocqJustyna KanoldPublished in: Journal of clinical apheresis (2020)
Hematopoietic progenitor cells-apheresis (HPC-A) collection is now a routine procedure for autologous hematopoietic stem cell transplantation. Here we present our 25 years' experience of HPC-A collection in children weighing 8 kg or less, with a focus on the evolution of our standard operating procedures, and the safety limits for these young patients, in the Pediatric Apheresis Unit of Clermont-Ferrand University Hospital (France). Fifteen children weighing 8 kg or less underwent 26 HPC-A collections over 25 years. Median CD34+ cell yield by leukapheresis was 4.4 106 /kg. No procedure-related complications were encountered during or after the collection. No patient had profound thrombocytopenia or anemia that needed post-collection transfusions. Our experience in pediatric oncology patients who underwent HPC-A collections shows that this procedure can be performed even in the smallest of children with no increase in toxicity provided all precautions are taken to ensure that the procedure is carried out under the ideal conditions.
Keyphrases
- end stage renal disease
- young adults
- stem cells
- chronic kidney disease
- ejection fraction
- newly diagnosed
- peripheral blood
- minimally invasive
- body weight
- prognostic factors
- peritoneal dialysis
- acute myeloid leukemia
- single cell
- oxidative stress
- patient reported outcomes
- mesenchymal stem cells
- case report
- patient reported
- clinical practice
- autism spectrum disorder
- middle aged